HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

R-BC154

a fluorescent alpha9beta1 integrin antagonist; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - R-BC154: 1
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Xanthenes: 65
      - Rhodamines: 466
        R-BC154: 1

Experts

1.	Cao, Benjamin: 1 article (02/2014)
2.	Haylock, David N: 1 article (02/2014)
3.	Heazlewood, Shen Y: 1 article (02/2014)
4.	Hutt, Oliver E: 1 article (02/2014)
5.	Li, Songhui: 1 article (02/2014)
6.	Nilsson, Susan K: 1 article (02/2014)
7.	Savage, G Paul: 1 article (02/2014)
8.	Smith, Jessica A: 1 article (02/2014)
9.	Williams, Brenda: 1 article (02/2014)
10.	Zhang, Zhen: 1 article (02/2014)

Related Diseases

1.	Glioblastoma (Glioblastoma Multiforme) 02/14/2014 - "Using transfected human glioblastoma LN18 cells, we show that R-BC154 exhibits high nanomolar binding affinities to α9β1 integrin with potent cross-reactivity against α4β1 integrin under physiological mimicking conditions. "

Related Drugs and Biologics

1.	Integrins